These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7542523)

  • 1. Molecular approaches to AIDS vaccine development using baculovirus expression vectors.
    Kang CY
    Methods Mol Biol; 1995; 39():295-315. PubMed ID: 7542523
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HIV-2 Gag and Env antigens in E. coli.
    Ulrich R; Siakkou H; Krüger DH
    Acta Virol; 1992 Oct; 36(5):491. PubMed ID: 1364028
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S73-5. PubMed ID: 7532425
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A; Voss G; Hunsmann G
    Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.
    Cheynet V; Verrier B; Mallet F
    Protein Expr Purif; 1993 Oct; 4(5):367-72. PubMed ID: 8251747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A; Ladha A; Cohen EA; Menezes J
    Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system.
    Yamshchikov GV; Ritter GD; Vey M; Compans RW
    Virology; 1995 Dec; 214(1):50-8. PubMed ID: 8525638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.
    McGettigan JP; Koser ML; McKenna PM; Smith ME; Marvin JM; Eisenlohr LC; Dietzschold B; Schnell MJ
    Virology; 2006 Jan; 344(2):363-77. PubMed ID: 16226782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 primary infection in two pairs of patients: difference in variants transmitted and clinical follow-up.
    Innocenti-Francillard P; Brengel-Pesce K; Morand P; Ounanian-Paraz A; Leclercq P; Gruters R; Seigneurin JM
    AIDS; 1997 Mar; 11(4):539-42. PubMed ID: 9084806
    [No Abstract]   [Full Text] [Related]  

  • 17. Biodiversity and bioseparation of HIV-1 envelope glycoproteins.
    Shao Y; Lu Y
    Crit Rev Oncog; 1999; 10(1-2):1-16. PubMed ID: 10327209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple procedure to generate chimeric Pr55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1.
    Brand D; Mallet F; Truong C; Roingeard P; Goudeau A; Barin F
    J Virol Methods; 1995 Feb; 51(2-3):153-68. PubMed ID: 7537750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assay for simultaneous detection of HIV p24 antigen and anti-HIV antibody].
    Xu K; Zhang Y; Wang Y; Mbawuike I
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):377-9. PubMed ID: 12665911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in methods for the production, purification, and characterization of HIV-1 Gag-Env pseudovirion vaccines.
    Hammonds J; Chen X; Zhang X; Lee F; Spearman P
    Vaccine; 2007 Nov; 25(47):8036-48. PubMed ID: 17936444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.